Adele, let's start with the moment everyone keeps asking about. You were on Mounjaro. You were on the most expensive weight-loss drug money can buy. Your doctor in Beverly Hills was charging you £1,200 a month. And one night in 2024 something happened that made you throw the entire prescription in the bin. Tell me about that night.

It was the third time that week I'd been on the bathroom floor at 3 in the morning. Sweating. Sick. The pain in my stomach was so bad I couldn't stand up. My daughter heard me, came to the door (she was eight at the time), and she said, "Mummy, are you going to die?"

That was the moment, Sanjay. Not the weight. Not the scale. That. My little girl thinking her mum was going to die in the bathroom because a doctor in Beverly Hills told me Mounjaro was the answer. I sat on that floor and I sobbed.

Then I got angry. Properly angry. I'd been a good patient. I'd done what the experts told me. I'd paid the money. I'd taken the injections. And I was getting sicker. Not thinner. Sicker.

The next morning I rang my mum in Tottenham. She'd had her hip replaced two years before and her doctor had put her on Ozempic for the diabetes. Same thing. Constantly nauseous. Couldn't keep food down. She'd lost 6lbs in a year and looked ten years older. And I just thought, this is the system. This is what they sell us. Slow poison at £200 a week, and we're supposed to be grateful.

You then made a phone call that, I'm told, changed the course of this whole story. You rang a friend, a chemistry professor at Imperial College London. What did he tell you?

He didn't sugarcoat it. He said, "Adele, Ozempic and Wegovy only work on one of your three fat-burning hormones. Mounjaro works on two. And after about twelve weeks your body adapts and they stop working. That's why you're sick. Your body is screaming at you that something is wrong."

Then he said something that floored me. He said, "There is a third drug. It works on all three hormones at once. It was being trialled in Manchester. The Americans tried to buy the lab three times. The lab said no."

That lab was Body Pharm. The drug was Retatrutide. And I was on a flight to Manchester the next morning.

Let me make sure our viewers understand this. Ozempic targets GLP-1. Mounjaro targets GLP-1 plus GIP. You're telling me Retatrutide targets a third hormone, Glucagon, and that is why your body stopped fighting back?

And the results? In your own words. Don't be modest.

Fourteen days in, my husband walked into the kitchen, looked at me, and stopped dead. He said, "Your face is back." I started crying right there at the breakfast table. I hadn't seen my own cheekbones in seven years.

Three weeks in, I had to throw out half my wardrobe. The clothes were sliding off me when I walked. My eight-year-old came home from school, saw me, dropped her bag, and ran. She didn't recognise me from behind. That is the moment I will remember until I die.

By month three I'd lost 100 pounds. No starving. No 5am spin classes. No Beverly Hills "wellness coach" charging me a grand a week. Just one injection, once a week, no nausea. I slept through the night for the first time since 2017.

And I thought, every woman in Britain deserves to know about this. Every. Single. One.

Adele, and I want to be very careful how I ask this, we have been told by multiple sources that two major American pharmaceutical companies have personally contacted your management in the last six months. We've been told there were lawyers involved. We've been told there was talk of a "subscription model" they wanted you to publicly endorse instead. Is any of that true?

All of it. Every word.

Eight months ago, two of the biggest GLP-1 manufacturers in the world flew their executives to London. They sat in my lawyer's office and they made me an offer. They wanted me to stop talking about Body Pharm. They wanted me to launch what they called a "Mounjaro+ subscription." £349 a month, auto-billed, locked in for life. They wanted my face on it. They offered me a number that would make most people stop talking.

I told them no. Then I told them why.

I said, "You are about to put a subscription wall between British women and the drug that actually saves their lives. And I am going to spend the rest of my career making sure that doesn't happen." Then I rang Body Pharm and I told them I would personally fund their UK distribution. I'm not just a customer of this company, Sanjay. I'm an investor. I went all in. Because someone had to.

That's why this pen is £14 a week and not £349 a month. That is the only reason.

The pharmaceutical industry will not be happy this interview aired. I'm told 60 Minutes received three separate legal letters in the 72 hours before broadcast. What do you say to the viewers watching tonight who want to try this pen but feel afraid?

I'd say, act fast. Body Pharm's UK warehouse is in Manchester. They ship in 2 to 4 working days. There's no prescription. There's no GP appointment. There's no waiting list. But I'm not going to lie to you. Stock is being smashed.

London sold out within 11 hours of last Tuesday's preview clip going up. Manchester went the next morning. Body Pharm told me yesterday they have under 300 pens left in this week's UK allocation. The next shipment is 14 to 21 days away, and when it lands the price is going up. Because pharma's pressure on the supply chain is brutal right now.

So if you're watching this tonight, and you've ever cried in a changing room, or hidden from a family photo, or lain awake at 2 in the morning hating your own body: tonight is the night you stop waiting.

I've made them put a link in this article. Use it. Skip the queue. And remember, I had to fight for this. I am still fighting for this. Don't waste it.